Jeffrey M. Leiden - Jul 25, 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Executive Chairman, Director
Signature
/s/ Joy Liu, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Jul 25, 2022
Transactions value $
-$31,670,341
Form type
4
Date filed
7/27/2022, 04:17 PM
Previous filing
Apr 14, 2022
Next filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Options Exercise $5.49M +60.3K +81.37% $91.05 135K Jul 25, 2022 Direct
transaction VRTX Common Stock Sale -$3.88M -13.9K -10.31% $279.44 121K Jul 25, 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale -$9.25M -33K -27.34% $280.37 87.7K Jul 25, 2022 Direct F1, F2, F4
transaction VRTX Common Stock Sale -$9.59M -34.1K -38.89% $281.27 53.6K Jul 25, 2022 Direct F1, F2, F5
transaction VRTX Common Stock Sale -$11.5M -40.7K -75.93% $282.43 12.9K Jul 25, 2022 Direct F1, F2, F6
transaction VRTX Common Stock Sale -$2.97M -10.5K -81.21% $283.42 2.42K Jul 25, 2022 Direct F1, F2, F7
holding VRTX Common Stock 440 Jul 25, 2022 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRTX Stock Option (Right to Buy) Options Exercise $0 -60.3K -64.29% $0.00 33.5K Jul 25, 2022 Common Stock 60.3K $91.05 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.
F2 Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $279.44 (range $278.90 to $279.89).
F4 Open market sales reported on this line occurred at a weighted average price of $280.37 (range $279.90 to $280.88).
F5 Open market sales reported on this line occurred at a weighted average price of $281.27 (range $280.90 to $281.89).
F6 Open market sales reported on this line occurred at a weighted average price of $282.43 (range $281.90 to $282.89).
F7 Open market sales reported on this line occurred at a weighted average price of $283.42 (range $282.90 to $283.84).
F8 Fully vested.